ZA956925B - Estradiol-TTS having water-binding additives - Google Patents

Estradiol-TTS having water-binding additives

Info

Publication number
ZA956925B
ZA956925B ZA956925A ZA956925A ZA956925B ZA 956925 B ZA956925 B ZA 956925B ZA 956925 A ZA956925 A ZA 956925A ZA 956925 A ZA956925 A ZA 956925A ZA 956925 B ZA956925 B ZA 956925B
Authority
ZA
South Africa
Prior art keywords
pct
water
estradiol
tts
matrix
Prior art date
Application number
ZA956925A
Other languages
English (en)
Inventor
Walter Mueller
Michael Horstmann
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA956925B publication Critical patent/ZA956925B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
ZA956925A 1994-08-20 1995-08-18 Estradiol-TTS having water-binding additives ZA956925B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4429667A DE4429667C2 (de) 1994-08-20 1994-08-20 Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ZA956925B true ZA956925B (en) 1996-03-25

Family

ID=6526231

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA956925A ZA956925B (en) 1994-08-20 1995-08-18 Estradiol-TTS having water-binding additives

Country Status (22)

Country Link
US (1) US5902602A (ko)
EP (1) EP0776199B1 (ko)
JP (1) JP3825799B2 (ko)
KR (1) KR100401136B1 (ko)
CN (1) CN1078461C (ko)
AT (1) ATE185067T1 (ko)
AU (1) AU695970B2 (ko)
CZ (1) CZ289397B6 (ko)
DE (2) DE4429667C2 (ko)
DK (1) DK0776199T3 (ko)
ES (1) ES2139932T3 (ko)
FI (1) FI118720B (ko)
GR (1) GR3032218T3 (ko)
HU (1) HU226959B1 (ko)
IL (1) IL114949A (ko)
MX (1) MX9701302A (ko)
NO (1) NO313984B1 (ko)
NZ (1) NZ291813A (ko)
PL (1) PL180965B1 (ko)
SK (1) SK281626B6 (ko)
WO (1) WO1996005814A1 (ko)
ZA (1) ZA956925B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
DE19713141A1 (de) * 1996-03-29 1997-10-30 Labtec Gmbh Transdermales System mit Melatonin
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
US10493049B2 (en) 2016-02-10 2019-12-03 Niracle LLC Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations
WO2023081539A1 (en) 2021-11-08 2023-05-11 Weiyong Li Transdermal drug delivery system for delivering a drug to a patient

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040861B1 (en) * 1979-01-11 1985-04-17 Key Pharmaceuticals, Inc. Polymeric diffusion matrix and method of its preparation
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
CA1163559A (en) * 1980-07-09 1984-03-13 Alec D. Keith Polymeric diffusion matrix for administration of drugs
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
ZA853488B (en) * 1984-05-10 1986-12-30 American Home Prod Transdermal dosage form
US4810499A (en) * 1984-10-01 1989-03-07 Biotek, Inc. Transdermal drug delivery system and method
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
US4764379A (en) * 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
DD279818A1 (de) * 1989-02-06 1990-06-20 Jenapharm Veb Verfahren zur herstellung eines medizinischen pflasters
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
AR246186A1 (es) * 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
DE69326461T2 (de) * 1992-06-11 2000-05-04 Theratech Inc Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
JP3489831B2 (ja) * 1993-04-20 2004-01-26 ヘクサル・アクチエンゲゼルシャフト 活性成分パッチ

Also Published As

Publication number Publication date
DK0776199T3 (da) 2000-04-10
CN1078461C (zh) 2002-01-30
MX9701302A (es) 1998-05-31
IL114949A0 (en) 1995-12-08
IL114949A (en) 1998-12-27
US5902602A (en) 1999-05-11
EP0776199A1 (de) 1997-06-04
CN1155835A (zh) 1997-07-30
NZ291813A (en) 1998-01-26
FI970701A (fi) 1997-02-19
ES2139932T3 (es) 2000-02-16
JPH10504313A (ja) 1998-04-28
FI118720B (fi) 2008-02-29
AU695970B2 (en) 1998-08-27
HU226959B1 (en) 2010-03-29
DE59506962D1 (de) 1999-11-04
KR100401136B1 (ko) 2004-03-31
PL319013A1 (en) 1997-07-21
NO970360L (no) 1997-01-28
NO970360D0 (no) 1997-01-28
FI970701A0 (fi) 1997-02-19
GR3032218T3 (en) 2000-04-27
CZ50997A3 (en) 1997-06-11
DE4429667C2 (de) 1996-07-11
ATE185067T1 (de) 1999-10-15
NO313984B1 (no) 2003-01-13
JP3825799B2 (ja) 2006-09-27
PL180965B1 (pl) 2001-05-31
DE4429667A1 (de) 1996-02-22
AU3344995A (en) 1996-03-14
SK22097A3 (en) 1997-07-09
HUT77085A (hu) 1998-03-02
CZ289397B6 (cs) 2002-01-16
KR970705381A (ko) 1997-10-09
EP0776199B1 (de) 1999-09-29
WO1996005814A1 (de) 1996-02-29
SK281626B6 (sk) 2001-05-10

Similar Documents

Publication Publication Date Title
PT739199E (pt) Adesivo de estradiol com agente reforcador da penetracao
ATE165736T1 (de) Wirkstoffhaltiges pflaster
ZA947240B (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid
AU695970B2 (en) Estradiol-TTS having water-binding additives
PL319014A1 (en) Transdermal therapeutic system containing estradiol and water bonding additives
ES2105334T3 (es) Sistema terapeutico percutaneo para la administracion de fisostigmina en la piel y el procedimiento para su obtencion.
CA2197867A1 (en) Oestradiol transdermal therapeutic system comprising hygroscopic additives